BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23516127)

  • 1. Clinicopathological significance of L-type amino acid transporter 1 (LAT1) expression in patients with adenoid cystic carcinoma.
    Kaira K; Toyoda M; Shino M; Sakakura K; Takahashi K; Tominaga H; Oriuchi N; Kanai Y; Oyama T; Chikamatsu K
    Pathol Oncol Res; 2013 Oct; 19(4):649-56. PubMed ID: 23516127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer.
    Kaira K; Sunose Y; Ohshima Y; Ishioka NS; Arakawa K; Ogawa T; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Itoh H; Nagamori S; Kanai Y; Yamaguchi A; Segawa A; Ide M; Mori M; Oyama T; Takeyoshi I
    BMC Cancer; 2013 Oct; 13():482. PubMed ID: 24131658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
    Toyoda M; Kaira K; Shino M; Sakakura K; Takahashi K; Takayasu Y; Tominaga H; Oriuchi N; Nikkuni O; Suzuki M; Iijima M; Tsukamoto N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Head Neck; 2015 Nov; 37(11):1569-74. PubMed ID: 24913970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.
    Toyoda M; Kaira K; Ohshima Y; Ishioka NS; Shino M; Sakakura K; Takayasu Y; Takahashi K; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Br J Cancer; 2014 May; 110(10):2506-13. PubMed ID: 24762957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer.
    Kaira K; Sunose Y; Arakawa K; Ogawa T; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Itoh H; Nagamori S; Kanai Y; Segawa A; Furuya M; Mori M; Oyama T; Takeyoshi I
    Br J Cancer; 2012 Aug; 107(4):632-8. PubMed ID: 22805328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.
    Sun J; Luo Y; Tian Z; Gu L; Xia SC; Yu Y
    BMC Cancer; 2012 Oct; 12():499. PubMed ID: 23110497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
    Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
    Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of LAT1 and ASCT2 in patients with surgically resected esophageal squamous cell carcinoma.
    Honjo H; Kaira K; Miyazaki T; Yokobori T; Kanai Y; Nagamori S; Oyama T; Asao T; Kuwano H
    J Surg Oncol; 2016 Mar; 113(4):381-9. PubMed ID: 26936531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of LAT1 and CD98 expression in cutaneous angiosarcoma.
    Shimizu A; Kaira K; Okubo Y; Utsumi D; Yasuda M; Tominaga H; Oriuchi N; Kanai Y; Takahashi K; Ishikawa O
    Neoplasma; 2017; 64(2):283-288. PubMed ID: 28052681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ER stress markers (GRP78/BiP and PERK) in adenoid cystic carcinoma.
    Kaira K; Toyoda M; Shimizu A; Shino M; Sakakura K; Takayasu Y; Takahashi K; Asao T; Chikamatsu K
    Acta Otolaryngol; 2016; 136(1):1-7. PubMed ID: 26366837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma.
    Isoda A; Kaira K; Iwashina M; Oriuchi N; Tominaga H; Nagamori S; Kanai Y; Oyama T; Asao T; Matsumoto M; Sawamura M
    Cancer Sci; 2014 Nov; 105(11):1496-502. PubMed ID: 25220100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
    Bazarsad S; Kim JY; Zhang X; Kim KY; Lee DY; Ryu MH; Kim J
    Yonsei Med J; 2018 Aug; 59(6):717-726. PubMed ID: 29978608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.
    Kaira K; Kawashima O; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Sugano M; Yamamoto R; Osaki T; Tanaka S; Fujita A; Imai H; Kogure Y; Seki Y; Shimizu K; Mogi A; Shitara Y; Oyama T; Kanai Y; Asao T
    Hum Pathol; 2019 Feb; 84():142-149. PubMed ID: 30300664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.
    Nikkuni O; Kaira K; Toyoda M; Shino M; Sakakura K; Takahashi K; Tominaga H; Oriuchi N; Suzuki M; Iijima M; Asao T; Nishiyama M; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Pathol Oncol Res; 2015 Sep; 21(4):1175-81. PubMed ID: 26024742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Cancer Sci; 2008 Dec; 99(12):2380-6. PubMed ID: 19018776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma.
    Kaira K; Oriuchi N; Takahashi T; Nakagawa K; Ohde Y; Okumura T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Kanai Y; Endo M; Kondo H; Nakajima T; Yamamoto N
    Anticancer Res; 2011 Dec; 31(12):4075-82. PubMed ID: 22199264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Cancer Sci; 2009 Feb; 100(2):248-54. PubMed ID: 19068093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of p53 immunohistochemical expression in adenoid cystic carcinoma of the salivary glands: a meta-analysis.
    Li Q; Huang P; Zheng C; Wang J; Ge M
    Oncotarget; 2017 Apr; 8(17):29458-29473. PubMed ID: 28206977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.